Literature DB >> 2993509

Interaction of opiates with opioid binding sites in the bovine adrenal medulla: I. Interaction with delta and mu sites.

E Castanas, N Bourhim, P Giraud, F Boudouresque, P Cantau, C Oliver.   

Abstract

In the present study we examined the interaction of opiates with the delta and mu opioid binding sites in the bovine adrenal medulla. [3H][D-Ala2, D-Leu5]-enkephalin ( [3H]DADLE) in the presence of saturating concentrations of morphiceptin was used to analyze delta site interactions, whereas either [3H]DADLE in the presence of saturation concentrations of [D-Ser2, Leu5]-enkephalin-Thr6 (DSLET) or [3H][D-Ala2, Me-Phe4, Gly5-ol]-enkephalin ( [3H]DAGO) was used for the determination of mu sites. Both binding sites were found to interact stereoselectively with opiates. The binding was affected differentially by proteolytic enzymes (trypsin, alpha-chymotrypsin, pepsin), N-ethylmaleimide, and A2-phospholipase. Kinetic and equilibrium binding studies revealed that in each case radiolabeled opiates interact with one class of binding sites, following simple second-order bimolecular kinetics. Competition for binding by opiates and opioid peptides confirmed the delta and mu selectivity of these sites. Monovalent (Na+, Li+, K+) and divalent (Mg2+, Mn2+, Ca2+) ions interacted differentially with these two binding sites: In general, monovalent cations affected preferentially the apparent number of binding sites, whereas divalent ions modified the equilibrium dissociation constant. Furthermore, positive or negative cooperativity and an apparent heterogeneity of binding sites were detected under some ionic conditions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993509     DOI: 10.1111/j.1471-4159.1985.tb04046.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

Review 1.  Peripheral modulation of learning and memory: enkephalins as a model system.

Authors:  G Schulteis; J L Martinez
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Psychedelics and the human receptorome.

Authors:  Thomas S Ray
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

3.  Identification of a novel opioid peptide (Tyr-Val-Pro-Phe-Pro) derived from human alpha S1 casein (alpha S1-casomorphin, and alpha S1-casomorphin amide).

Authors:  M Kampa; S Loukas; A Hatzoglou; P Martin; P M Martin; E Castanas
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

4.  Chronic exposure of neonatal rat adrenomedullary chromaffin cells to opioids in vitro blunts both hypoxia and hypercapnia chemosensitivity.

Authors:  Shaima Salman; Josef Buttigieg; Min Zhang; Colin A Nurse
Journal:  J Physiol       Date:  2012-11-12       Impact factor: 5.182

5.  Inhibitory effects of tramadol on nicotinic acetylcholine receptors in adrenal chromaffin cells and in Xenopus oocytes expressing alpha 7 receptors.

Authors:  Munehiro Shiraishi; Kouichiro Minami; Yasuhito Uezono; Nobuyuki Yanagihara; Akio Shigematsu; Izumi Shibuya
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

Review 6.  The Clash of Two Epidemics: the Relationship Between Opioids and Glucose Metabolism.

Authors:  Laura L Koekkoek; Luna L van der Gun; Mireille J Serlie; Susanne E la Fleur
Journal:  Curr Diab Rep       Date:  2022-05-20       Impact factor: 5.430

7.  Opioid receptor stimulation suppresses the adrenal medulla hypoxic response in sheep by actions on Ca(2+) and K(+) channels.

Authors:  Damien J Keating; Grigori Y Rychkov; Michael B Adams; Hans Holgert; I Caroline McMillen; Michael L Roberts
Journal:  J Physiol       Date:  2004-01-14       Impact factor: 5.182

8.  Effects of opioid peptides and morphine on histamine-induced catecholamine secretion from cultured, bovine adrenal chromaffin cells.

Authors:  B G Livett; P D Marley
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

9.  Receptorphin: a conserved peptide derived from the sequence of the opioid receptor, with opioid displacement activity and potent antiproliferative actions in tumor cells.

Authors:  M Kampa; S Loukas; A Tsapis; E Castanas
Journal:  BMC Pharmacol       Date:  2001-11-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.